For consumers who are injured by a drug or medical device, the first question that arises is often a simple one. They want to know how a product that was approved by the FDA could do them serious harm. The simple answer is that Food and Drug Administration (FDA) approval of a drug or device […]
Andrus Wagstaff Law Blog
Risperidal was the world’s first medication approved for treating autism in children, and it’s still the most widely prescribed. Upon initial release, it seemed like a miracle drug. Unquestionably, it effectively manages many of the behavioral difficulties associated with autism. The drug is also used in the treatment of schizophrenia and bipolar disorder. But for […]
Nobody likes an upper respiratory infection. Bacterial infections of any kind can be extremely serious and require medical attention. But what happens when the medicine your doctor prescribes solves one problem while causing another? We now know that fluoroquinolone antibiotics, which are commonly prescribed to treat upper respiratory infections and other bacterial infections, may directly […]
Here at Andrus Wagstaff, PC, we help people who’ve suffered injury as a result of dangerous drugs or defective products. Headquartered in Denver, we represent personal injury victims all across the country and fight for financial compensation on their behalf. We are a national mass tort law firm. You might be wondering what “mass tort” […]
The 2014 Litigator Award winners have been announced, and the Lakewood, Colorado-based trial law firm Andrus Wagstaff, PC, is proud to be among the recipients of what’s known as “the Oscars of Trial Law.” The Litigator Awards are handed out by the Trial Lawyers Board of Regents, LLC. According to the Board’s website, it each […]
$3 billion: that’s how much GlaxoSmithKline agreed to pay the U.S. Department of Justice in 2012 to settle civil and criminal charges related to its misbranding of the drugs Paxil and Wellbutrin and its failure to disclose safety information about the diabetes drug Avandia. Although the $3 billion fine was the largest fine ever levied […]
Fresenius Medical Care, the Waltham, Massachusetts-based manufacturer of dialysis solutions GranuFlo and NaturaLyte, is now facing approximately 6,000 lawsuits alleging that patients suffered severe injuries and were not warned about the risks associated with the products. The filing of lawsuits against Fresenius are preceded by a 2012 Food and Drug Administration (FDA) Class I recall […]
Two studies published recently in the prestigious medical journal JAMA Internal Medicine say that many of the medical devices approved by the Food and Drug Administration (FDA) lack evidence verifying their safety and effectiveness. One study, led by Dr. Diana Zuckerman, president of the National Center for Health Research, looked at moderate to high-risk medical […]
Despite the publication of a study that confirms an earlier government assessment that the use of laparoscopic power morcellators—devices used in minimally invasive uterine procedures—is risky, some gynecologists continue to use them. A number of health insurers, meanwhile, are no longer paying for morcellation, citing patient safety risks. The Food and Drug Administration (FDA) in […]
Johnson & Johnson subsidiary Janssen Pharmaceuticals, Inc., maker of the drug risperidone (Risperdal), which has been linked to male breast development, faces a new lawsuit in a New York District Court alleging that Risperdal caused a 21 year old man to undergo multiple surgeries that resulted in severe pain, injury and emotional suffering. Shaquil Bird […]
